| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |